Acute Limb Ischemia, Atheroembolization, and Compartment Syndrome

43.1Definition and presentation

Acute limb ischemia is a vascular emergency characterized by a sudden decrease in limb perfusion that threatens limb viability. The diagnosis is clinical and rests on serial bedside examination rather than appearance alone. Presentation dictates the timeline to revascularization, with motor and sensory deficits serving as the primary indicators of acute threat ESVS 2020 · Rutherford · 1997.

Bedside evaluation anchors on three objective findings:

• Sensory loss: Extent of sensory deficit, beginning in the toes and progressing proximally.
• Motor deficit: Presence of muscle weakness or paralysis.
• Doppler signals: Presence or absence of audible signals using a hand-held arterial and venous Doppler.

Atheroembolization (blue toe syndrome) presents with distal embolic or cholesterol-crystal ischemia that can mimic occlusive acute limb ischemia. It is a distinct pathological process requiring evaluation of proximal embolic sources rather than indiscriminate distal thrombolysis or embolectomy Blue Toe Review · 2025 · Cholesterol Embolization · 2010.

43.2Classification and risk stratification

The Rutherford classification standardizes acute limb ischemia severity and governs modality choice. Classification is dynamic; worsening sensory loss, new weakness, or loss of venous Doppler signals demands immediate escalation Rutherford · 1997.

• Class I (Viable): No immediate limb threat, no sensory loss, no muscle weakness, and audible arterial and venous Doppler signals.
• Class IIa (Marginally threatened): Salvageable with prompt treatment. Minimal sensory loss is confined to the toes, muscle weakness is absent, arterial Doppler is often inaudible, and venous Doppler is audible.
• Class IIb (Immediately threatened): Salvageable only with immediate revascularization. Sensory loss extends beyond the toes, rest pain is present, and mild to moderate muscle weakness is present. Arterial Doppler is inaudible; venous Doppler remains audible.
• Class III (Irreversibly damaged): Major tissue loss and permanent nerve injury are expected. Characterized by profound anesthesia, paralysis with rigor, and absent arterial and venous Doppler signals.

43.3Revascularization thresholds and modality choice

Therapeutic unfractionated heparin is initiated immediately upon confirmed or strongly suspected acute limb ischemia, provided no contraindications exist. Early anticoagulation prevents thrombus propagation while viability is assessed and intervention is planned ACC/AHA 2024 · ESVS 2020. Anticoagulation, analgesia, and urgent imaging proceed in parallel.

Revascularization strategy relies on ischemia severity, symptom duration, and bleeding risk. The occlusive mechanism sets the procedural fork within the same Rutherford class: embolic occlusion favors embolectomy plus a search for the cardiac or proximal embolic source, whereas in situ atherosclerotic thrombosis, including graft thrombosis, favors catheter-directed lysis, imaging of the culprit lesion, and bypass of the underlying disease ESVS 2020. Thrombolysis is primarily used for marginally threatened limbs or recent occlusions. STILE (1994) evaluated catheter-directed thrombolysis versus surgery in non-embolic ischemia. Overall 30-day outcomes favored surgery; however, thrombolysis yielded better amputation-free survival and shorter hospital stays for ischemia durations under 14 days, while surgery was favored for presentations beyond 14 days. Thrombolysis also reduced or avoided planned surgical procedures in over half of patients STILE · 1994.

TOPAS (1998) demonstrated equivalent 6-month amputation-free survival for initial recombinant urokinase compared to surgery (71.8% versus 74.8%). Thrombolysis reduced required surgical operations but carried a higher bleeding cost, including a 1.6% intracranial hemorrhage rate versus 0% for surgery TOPAS · 1998. Systematic review confirms no clear 30-day difference in limb salvage or mortality between initial surgery and thrombolysis, while thrombolysis carries higher rates of major hemorrhage and distal embolization Cochrane 2018.

The management algorithm follows an established sequence:

1. Unfractionated heparin is initiated immediately unless contraindicated.
2. Rutherford class is assigned at the bedside using objective neurological and Doppler anchors.
3. Viable or marginally threatened limbs undergo urgent imaging and endovascular or open intervention tailored to symptom duration.
4. Immediately threatened limbs proceed directly to open, hybrid, or rapid mechanical revascularization without diagnostic delay.
5. Irreversible limbs fall outside the revascularization pathway and are routed to primary amputation or palliative care. Selected patients without irreversible ischemia also fall outside the pathway when the limb, the patient, or the goals of care make intervention nonbeneficial; nonrevascularization is an explicit, documented decision covering the viability assessment, the rationale, and the plan for anticoagulation, amputation, palliation, or surveillance, never therapeutic drift ESVS 2020.
6. Compartment syndrome risk is assessed following reperfusion.

43.4Post-revascularization and compartment syndrome

Reperfusion triggers swelling, metabolic stress, and recurrent thrombosis risk. Current guidelines recommend prophylactic four-compartment fasciotomy alongside high-risk revascularization, specifically for prolonged ischemia, delayed presentation, or significant reperfusion swelling ACC/AHA 2024 · ACC/AHA 2024. Delayed fasciotomy risks permanent neuromuscular injury, while unnecessary decompression introduces wound morbidity Delayed Fasciotomy · 2019.

Post-revascularization compartment syndrome is a clinical diagnosis. When clinical signs are equivocal or patient assessment is unreliable, quantitative compartment-pressure measurement is used, conventionally referencing the Whitesides needle-manometer method or modern solid-state and slit catheters Whitesides 1975. The operative threshold is a differential pressure (diastolic blood pressure minus compartment pressure) of less than 30 mmHg, a metric derived to identify necessary decompression while avoiding unnecessary fasciotomies McQueen 1996.

Anticoagulation following intervention is transitioned to targeted secondary-prevention antithrombotic therapy based on the occlusive mechanism, bleeding risk, and the specific procedure performed ACC/AHA 2024.

43.5Areas of controversy

Several aspects of acute limb ischemia management remain debated without consensus guidelines:

• The absolute application of the 30 mmHg delta-pressure fasciotomy threshold. The metric was validated in a tibial-fracture cohort and its direct translation to the ischemic reperfusion population requires clinical caution McQueen 1996 · Losee 1996.
• The efficacy of initial thrombolysis in exclusively embolic acute limb ischemia, as foundational evidence like the STILE trial explicitly evaluated non-embolic presentations STILE · 1994.
• The precise selection algorithm between catheter-directed thrombolysis and modern single-session aspiration or rotational mechanical thrombectomy, as landmark comparative trials predate contemporary endovascular adjuncts STILE · 1994 · Aspiration Thrombectomy · 2023 · Rotarex ALI 2020.